Results for
"[search-keyword]"
Sponsor content
3 result(s) found, displaying 1 to 3
-
Australian Public Assessment Report (AusPAR)Hemgenix (etranacogene dezaparvovec), a gene therapy, has been approved for the treatment of haemophilia B (congenital factor IX deficiency) in adults.
-
Prescription medicine decision summaryHemgenix (etranacogene dezaparvovec) has been approved for the treatment of adults with haemophilia B (congenital factor IX deficiency).
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Albutrepenonacog alfa (rch)